Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Journey Medical Corporation · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $240.14M | $225.84M - $255.63M | -$49.03M | $1.70 | 1 |
| Dec 2029 | $224.53M | $211.16M - $239.01M | -$45.84M | $1.415 | 1 |
| Dec 2028 | $198.48M | $186.67M - $211.29M | -$40.52M | $2.245 | 2 |
| Dec 2027 | $137.73M | $133.47M - $142.00M | -$28.12M | $1.038 | 3 |
| Dec 2026 | $82.62M | $81.67M - $83.56M | -$16.87M | $0.065 | 3 |
| Dec 2025 | $64.65M | $63.89M - $65.41M | -$13.20M | -$0.48 | 3 |
| Dec 2024 | $56.52M | $55.90M - $57.14M | -$11.54M | -$1.00 | 3 |
| Dec 2023 | $80.00M | $75.52M - $85.61M | -$16.33M | -$0.222 | 2 |
| Dec 2022 | $74.27M | $73.15M - $75.97M | -$11.15M | -$1.557 | 1 |
| Dec 2021 | $66.01M | $65.01M - $67.52M | -$9.91M | -$2.62 | 1 |